Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Momenta PharmaceuticalsAcceleron PharmaCRISPR TherapeuticsAdaptive BiotechnologiesIovance Biotherapeutics
SymbolNASDAQ:MNTANASDAQ:XLRNNASDAQ:CRSPNASDAQ:ADPTNASDAQ:IOVA
Price Information
Current Price$52.48$113.75$110.00$45.83$37.94
52 Week RangeHoldBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score0.71.41.11.41.9
Analysis Score1.22.42.32.44.5
Community Score2.53.02.62.43.2
Dividend Score0.00.00.00.00.0
Ownership Score0.01.70.81.71.7
Earnings & Valuation Score0.00.00.00.60.0
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$48.44$126.92$104.43$55.80$47.50
% Upside from Price Target-7.69% downside11.58% upside-5.06% downside21.75% upside25.20% upside
Trade Information
Market Cap$6.25 billion$6.85 billion$7.77 billion$6.27 billion$5.57 billion
Beta1.710.592.260.270.94
Average Volume1,939,894571,9851,000,8481,078,7471,691,526
Sales & Book Value
Annual Revenue$23.87 million$73.99 million$289.59 million$85.07 millionN/A
Price / Sales261.6992.6326.8473.68N/A
CashflowN/AN/A$1.30 per shareN/AN/A
Price / CashN/AN/A84.58N/AN/A
Book Value$4.59 per share$8.47 per share$19.01 per share$5.67 per share$2.37 per share
Price / Book11.4313.435.798.08N/A
Profitability
Net Income$-290,050,000.00$-124,860,000.00$66.86 million$-68,610,000.00$-197,560,000.00
EPS($3.03)($2.38)$1.17($1.01)($1.59)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-757.61%-157.84%-273.10%-132.32%N/A
Return on Equity (ROE)-61.44%-31.62%-20.72%-20.15%-59.35%
Return on Assets (ROA)-45.28%-28.11%-18.35%-13.09%-53.22%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio6.38%12.02%16.53%8.70%14.26%
Quick Ratio6.38%12.02%16.53%8.59%14.25%
Ownership Information
Institutional Ownership PercentageN/A79.78%55.19%73.67%95.15%
Insider Ownership Percentage3.40%2.50%17.10%22.20%9.90%
Miscellaneous
Employees131237304453148
Shares Outstanding119.03 million60.25 million70.65 million136.77 million146.69 million
Next Earnings DateN/A2/25/2021 (Estimated)2/10/2021 (Estimated)2/24/2021 (Estimated)2/23/2021 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.